Cost containment by peer prior authorization program for second line treatment in patients with retinal disease

Cost containment by peer prior authorization program for second line treatment in patients with retinal disease

Abstract Background High and increasing drug prices have prompted the establishment of a broad range of cost-containment treatment policies in health systems globally. In 2012, the supplemental insurance program of a large Israeli health maintenance organization (Clalit Health Services) introduced a...

Full description

Bibliographic Details
Main Authors: Amir Rosenblatt, Igal Hekselman, Irit Rosenblatt, Idan Hekselman, Dan Gaton
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Israel Journal of Health Policy Research
Subjects:
Cost-containment
Retinal disease
Gatekeeping
Sentinel
Ethical dilemma
Ranibizumab
Online Access:https://doi.org/10.1186/s13584-021-00437-1

Internet

https://doi.org/10.1186/s13584-021-00437-1

Similar Items